SMALL CELL OVARIAN CARCINOMA

Clinical trials for SMALL CELL OVARIAN CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new SMALL CELL OVARIAN CARCINOMA trials appear

Sign up with your email to follow new studies for SMALL CELL OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for young women battling rare, deadly ovarian cancer

Disease control Recruiting now

This study is testing whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy can better control a rare and aggressive type of ovarian cancer. It aims to help young women with this disease, which currently has a very poor outlook. The main goal is to see if …

Matched conditions: SMALL CELL OVARIAN CARCINOMA

Phase: PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SMALL CELL OVARIAN CARCINOMA

Get alerted when new SMALL CELL OVARIAN CARCINOMA trials appear

New hope for young women battling rare, deadly ovarian cancer